✦ LIBER ✦

Calcium channel blocker use and mortality among patients with end-stage renal disease

✍ Scribed by Kestenbaum, Bryan; Gillen, Daniel L.; Sherrard, Donald J.; Seliger, Steven; Ball, Adrianne; Stehman-Breen, Catherine

Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 82 KB
Volume: 61
Category: Article
ISSN: 0085-2538
DOI: 10.1046/j.1523-1755.2002.00355.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elevated risk of stroke among patients w

Elevated risk of stroke among patients with end-stage renal disease

✍ Seliger, Stephen L.; Gillen, Daniel L.; Longstreth, W.T.; Kestenbaum, Bryan; Ste 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 292 KB

## Background: Although end-stage renal disease (esrd) has been associated with accelerated vascular disease of the cerebral circulation, there are no prior studies that have estimated the risk of hemorrhagic and ischemic stroke among the united states dialysis population relative to the general po

Hypoalbuminemia and risk of death in ped

Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease

✍ Wong, Craig S.; Hingorani, Sangeeta; Gillen, Daniel L.; Sherrard, Donald J.; Wat 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 211 KB

The use of specialized patient medicatio

The use of specialized patient medication information sheets with end stage renal disease patients: A pilot study

✍ Jack E. Fincham 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 709 KB

Patient medication information sheets specifically tailored to dialysis patient drug therapies were formulated for use in an artificial kidney center. Assessment of the drug-therapy knowledge of a patient sample pointed out the need for such a specific educational intervention. Results indicated tha

Alpha and gamma tocopherol metabolism in

Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease

✍ Himmelfarb, Jonathan; Kane, Jane; Mcmonagle, Ellen; Zaltas, Eric; Bobzin, Steve; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 537 KB

## Background: The metabolism of alpha and gamma tocopherol, the major components of vitamin e, have not been studied in uremic patients. the major pathway of tocopherol metabolism is via phytyl side chain oxidation, leaving carboxyethyl-hydroxychromans (cehc) as metabolites. alpha and gamma cehc a

The interaction of the calcium channel b

The interaction of the calcium channel blockers verapamil and nifedipine with cyclosporin A in pediatric renal transplant patients

✍ John F. S. Crocker; Kenneth W. Renton; Terry L. Vatte; D. Heather McLellan 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 494 KB

Use of calcium channel blockers and beta

Use of calcium channel blockers and beta blockers as antihypertensives in relation to mortality in type 2 diabetes patients: a population-based observational study

✍ Gunnar Lindberg; Jonny Olsson; Arne Melander 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 3 views

## Objectives: In previous trials, patients with type 2 diabetes using calcium channel blockers (ccb) have suffered a less favourable outcome when compared with patients on other treatments. the present study was designed to compare mortality in type 2 diabetes patients using either ccb or beta blo